Viviane Monges
CIK: 0001838204
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Sep 23, 2026PHVS
Pharvaris N.V.
Sale(S)Direct12K shares at avg. $33.05$396K - Sep 23, 2026PHVS
Pharvaris N.V.
Exercise(M)Direct12K shares at avg. $8.05$96K - Jun 3, 2026ADCT
ADC Therapeutics SA
Tax Payment(F)Direct2.6K shares at avg. $3.08$8K - Jun 1, 2026ADCT
ADC Therapeutics SA
Award(A)Direct45K shares- - May 21, 2026PHVS
Pharvaris N.V.
Sale(S)Direct9.7K shares at avg. $30.29$293K - Jun 13, 2025ADCT
ADC Therapeutics SA
Tax Payment(F)Direct2.6K shares at avg. $3.58$9K - Jun 3, 2025ADCT
ADC Therapeutics SA
Award(A)Direct40K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  PHVS Pharvaris N.V. | Sale(S) | 11,969 | $33.05 | $395,524 | Direct |
| Sep 23, 2026 | PHVS Pharvaris N.V. | Exercise(M) | 11,969 | $8.05 | $96,350 | Direct |
| Jun 3, 2026 |  ADCT ADC Therapeutics SA | Tax Payment(F) | 2,596 | $3.08 | $7,996 | Direct |
| Jun 1, 2026 | ADCT ADC Therapeutics SA | Award(A) | 45,000 | - | $0 | Direct |
| May 21, 2026 | PHVS Pharvaris N.V. | Sale(S) | 9,667 | $30.29 | $292,853 | Direct |
| Jun 13, 2025 | ADCT ADC Therapeutics SA | Tax Payment(F) | 2,584 | $3.58 | $9,251 | Direct |
| Jun 3, 2025 | ADCT ADC Therapeutics SA | Award(A) | 40,000 | - | - | Direct |
1-7 of 7 transactions
About Monges Viviane
Monges Viviane (SEC CIK 0001838204) files insider reports with the SEC as Director of Pharvaris N.V. (PHVS) and Director of ADC Therapeutics SA (ADCT).
Signal8 holds 6 ownership filings by Monges Viviane (1 Form 3, 5 Form 4), filed between Jun 5, 2025 and Sep 25, 2026. Those filings report 7 transactions, from Jun 3, 2025 to Sep 23, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Monges Viviane's filings is in LEXINGTON, MA.
Recent filings by Monges Viviane
- Sep 23, 2026: Open-market sale of PHVS shares (Form 4, code S).
- Sep 23, 2026: Option exercise of PHVS shares (Form 4, code M).
- Jun 3, 2026: Tax withholding of ADCT shares (Form 4, code F).
- Jun 1, 2026: Grant or award of ADCT shares (Form 4, code A).
- May 21, 2026: Open-market sale of PHVS shares (Form 4, code S).
Other insiders filing for Pharvaris N.V. (PHVS)
- Lu Peng, President
- Schikan Johannes Gerardus Christiaan Petrus, Director
- Nassif David W., CFO / CLO
- Bjork Elisabeth, Director
- Glassman Robert, Director
- Lesage Anne, Chief Early Development